In birds and mammals, vitamin D3 is 25-hydroxylated in the 24,25(OH)2D3 was identified by cochromatography with liver and converted to the prohormone 25(OH)D3, which underauthentic standard on four different HPLC systems, scan-goes further hydroxylation steps principally in the kidney. The ning UV spectrophotometry profile of the metabolite, sen-two major dihydroxylated metabolites produced in the kidney sitivity to periodate cleavage, and mass spectrometry of are 1,25(OH)zD3, which is the hormonal form of the vitamin (I), the putative placental 24,25(OH)2D3 and its periodate and 24,25(OH)2D3 (2, 3), a putative regulator of developmental cleavage product. We also identified for the first time bone formation (4-13). The biologic roles of the other known placental synthesis of 23,25(OH)2D3 using cochromatog-natural dihydroxylated vitamin D3 metabolites, 23,25(OH)2D3 raphy with authentic standard on two different HPLC and 26,25(OH)2D3, are not well understood. systems, scanning UV spectrophotometry, resistance to
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The observation that nephrectomized, vitamin D3-deficient periodate cleavage, and mass spectrometry. When troph-pregnant rats retain the ability to convert ['H]25(OH)D3 to [3H] oblast was incubated for up to 4 h with physiologic concen-1,25(OH)2D3 in vivo (14, 15) raised the possibility that extrarenal trations of [3H]25(OH)D:, (6 nM) significant amounts of sites produce 1,25(OH)2D3 during pregnancy. Subsequently, in [3H] 24,25(OH)2D3 were produced, but [3H]1,25(OH)2D3 vitro la-hydroxylation of 25(OH)D3 has been demonstrated in could not be consistently detected. In contrast, when we rat (14, 16), guinea pig (17) and human (18-22) placenta or incubated trophoblast with supraphysiologic concentra-decidua. In contrast to placental la-hydroxylation, 24R-hydroxtions of 25(OH)D3 (6-10 pM), both 24,25(OH)2D3 and ylation of 25(OH)D3 has not been thoroughly investigated. Sev-1,25(OH)2D3 were synthesized. These results provide un-eral reports have identified placenta as a possible site for 24-equivocal evidence for placental synthesis of both hydroxylation (16, 18-21), but none of these studies character-24,25(OH)2D3 and 23,25(OH)2D3. These findings also sug-ized the putative placental 24,25(OH)2D3 through more extensive gest that supraphysiologic substrate concentrations satu-chromatographic analysis or by mass spectrometry. Moreover, rate the placental 24-hydroxylase and may permit accu-recently Hollis et al. (22) failed to demonstrate any 24,25(OH)2D3 mulation of placental 1,25(OH)2D3 by preventing its fur-production by either human placental homogenates or subcelther metabolism. Consequently, the identification of this lular fractions, despite evidence for l,25(OH)2D3 production in high basal 24-hydroxylase activity in trophoblast may these preparations. These inconsistencies among previous reports explain inconsistencies among previous reports regarding prompted us to investigate whether placenta might possess a placental 1,25(OH)2D3 production. We speculate that ac-biologically important 25(OH)D3-24-hydroxylation pathway. tive placental 24-hydroxylation may serve important func-Like kidney, placenta apparently synthesizes 1,25(OH) 2D3 
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In the present study, we examined human placental 25(OH)D3 metabolism in several different culture systems. We present unequivocal evidence demonstrating that human placenta is a site for both 24,25(OH)2D3 and 23,25(OH)2D3 synthesis. Cytotrophoblasts were isolated by the method of Kliman et al. (32) with modifications. Briefly, minced villous tissue was digested with 0.125% (wt/vol) trypsin and 0.02% DNase. A cytotrophoblast-enriched cell fraction was purified by sequential centrifugations through discontinuous Percoll density gradients. Cells isolated in this manner are 295% cytotrophoblasts gauged by morphologic and immunocytochemical criteria (33) . When placed in culture, the mononuclear cytotrophoblasts aggregate, then fuse into syncytia approximately 72 h after plating. Cells were plated densely in either 35-mm cluster wells (5 to 7 x lo6 cells/well) or 60-mm culture dishes (lo7 cells/dish) and maintained in DMEM supplemented with 20 mM HEPES, 4 mM Lglutamine, antibiotics, and 15% (vol/vol) serum supplement (Nu-Serum IV, Collaborative Research, Bedford, MA). The concentration of fetal bovine serum in this complete medium is 3.75%. Cultures were refed with fresh medium every 24 h.
MATERIALS AND METHODS

Materials
Placental fibroblasts were isolated by trypsin-DNase or collagenase-hyaluronidase-DNase (34) dispersion followed by differential adhesion in 75-cm2 culture flasks. Fibroblasts were grown and serially passaged in DMEM supplemented with 4 mM Lglutamine, antibiotics, and 10% fetal bovine serum. Studies of 25(OH)D3 metabolism were performed upon confluent fibroblast monolayers grown in 60-mm culture dishes (third to fifth passages).
Fragments of placental villi measuring 5 2 mm2 (placental explants) were dissected from minced placental tissue and washed extensively in warm Hanks' buffered salt solution. Explants (51 g minced villi/100-mm plastic dish) were incubated in serumfree DMEM. Medium was changed daily for 1 to 4 d. Tissue viability during this period was demonstrated by maintenance of regulated expression and secretion of chorionic gonadotropin (Rubin LP, unpublished data).
Incitbations. The assays of 25(OH)D3 metabolism were camed out by incubating cells or tissue with graded concentrations of ['H]25(OH)D3 or unlabeled 25(OH)D3 or both for various time intervals at 37°C. Short-term cell and tissue incubations (5 min to 4 h) were performed using MEM with Eagle's salts, 20 mM HEPES, and 0.1 % BSA in a shaker water bath. Longer incubations (20 h) were performed using DMEM with 0.1 % BSA on a rocking platform in a humidified 5% (32195% air atmosphere. 25(OH)D3 was dissolved in ethanol and added to incubation media to a final concentration of 50.1 % (vol/vol). At the end of each incubation, cells or explants and media were collected together and added to one volume of methanol that contained authentic vitamin D3 metabolites for HPLC standardization and assessment of extraction efficiency. Explants were homogenized by using three to four bursts from a Polytron tissue grinder.
Lipid extraction. Lipid extraction was based on the procedure of Bligh and Dyer (39, except that methylene chloride was substituted for chloroform. Lipid was extracted in a separatory funnel and the organic phase was reduced to dryness under a stream of nitrogen. Samples were redissolved in mobile-phase solvent and subjected to analytic or preparative liquid chromatography in 200-pL aliquots.
Chromatography. HPLC was performed on a Waters model 600 liquid chromatograph equipped with a model 990 photodiode array detector (Waters Associates, Milford, MA). All analytical and semipreparative microparticulate silica gel straightphase columns (4.6 mm x 25 cm) were purchased from Dupont Instruments (Wilmington, DE). Flow rate in all instances was 2 mL/min. Various radioactive vitamin D3 metabolites were identified by their retention times, determined by cochromatography with unlabeled authentic standards. Timed elution fractions were collected and counted by liquid scintillography, and radioactivity in each peak was calculated. Additionally, in some experiments using micromolar concentrations of 25(OH)D3, metabolism of unlabeled 25(OH)D3 was also monitored by scanning spectrophotometry of the purified peaks for their UV (205-320 nm) profiles.
Metabolism of [3H]25(OH)D3 to [3H] 1 , 2 5 ( 0 H )~D~ by placental cells or explants was initially analyzed by chromatography of the lipid extracts on a Zorbax-SIL column equilibrated with a 6% isopropano1:hexane solvent system. A peak of [3H] radioactivity coeluting with the 1,25(OH)2D3 standard, obtained from the first HPLC system, was also analyzed by HPLC on a Zorbax-SIL column with a 3% isopropano1:methylene chloride solvent system and on a Zorbax-CN column with 4% isopropanol:hexane.
Production of [3H]24,25(OH)2D3 was initially analyzed using a Zorbax-SIL column with a 2% isopropano1:hexane solvent system. Aliquots of the apparent 24,25(OH)2D3 peak were subjected to further chromatographic analysis and purification using I ) a Zorbax-SIL column with 2% isopropano1:methylene chloride, 2) a Zorbax-SIL column with 5% isopropanol:hexane, 3) a Zorbax-CN column with 3% isopropanol:hexane, and 4) an amino column with 2% isopropano1:hexane.
Production of 23,25(OH)2D3 also was initially analyzed chromatographically on a Zorbax-SIL column with 2% isopropanokhexane. Further purification was achieved using a 1 % isopropano1:methylene chloride solvent system. Purified 23,25(OH)2D3 and 24,25(OH)2D3 peaks were dried, resuspended, and analyzed by mass spectrometry.
Periodate cleavage. Putative 24,25(OH)2D3 or 23,25(OH)2D3 was subjected to periodate cleavage (36) by adding 10 pL of 5% aqueous sodium metaperiodate to 0.5 pg of purified sample or standard dissolved in 15 pL of methanol. Reactions were camed out for 30 min at room temperature. The soluble material was subjected to chromatography on a Zorbax-SIL column eluted with 2% isopropanol:hexane. Purified periodate cleavage product peaks were dried, resuspended, and analyzed by mass spectrometry.
Mass spectrometry. Material derived from HPLC-purified peaks with the scanning UV trace characteristics A, , , = 265 nm, X,i, = 228 nm was subjected to electron impact mass spectrometry using a VG-7OSE double-focusing mass spectrometer with an E/B configuration (VG Analytical, Manchester, UK) and fitted with a direct insertion probe. Samples (-0.5 pg) in hexane:isopropanol:methanol (241511) , , , 24,25(OH)2D3 from 8.2 to 13.1 % of applied radioactivity (Table  1) . During time-course experiments extending to 4 h, a peak of radioactivity frequently eluted in the expected position of n 1,25(OH)2D3. As shown in Figure lA (Fig. 1 B) . Identijlcation of placental 24,25(0H)2D3. The putative 24,25(OH)2D3 peak was subjected to further preparative chro-cleavage), 253 (27 1-H20), 136 (cis-triene cleavage), and 1 18 (1 36-matography using a methylene chloride-based solvent system, HzO) mimic the published mass spectrum for this compound then subjected to periodate cleavage. Both the native metabolite (39) . and its periodate cleavage product eluted as single peaks with the IdentiJication of placental 23,25(OH)2D3. These placental expected retention times (Fig. 4) and were then subjected to mass 25(OH)D3 incubations produced a second metabolite in a molar spectrometry. Injection of approximately 0.5 pg of placental ratio of approximately 1:10 compared with 24,25(OH)2D3. This 24,25(OH)2D3 emitted a molecular ion at m/z 416 and charac-metabolite was further characterized as 23,25(OH)2D3 by HPLC teristic fragment peaks similar to the mass spectrum reported by using hexane-and methylene chloride-based solvent systems Holick et al. (39) (data not shown). The mass spectrum of the and by demonstrating the compound's resistance to periodate 24,25(OH)2D3 periodate cleavage product (Fig. 5) showed a cleavage (data not shown). The mass spectrum of this placental molecular ion at m/z 356, which results from cleavage of the 23,25(OH)2D3 peak (Fig. 6 ) revealed a molecular ion at m/z 41 6. C24-C25 bond yielding the corresponding 24-aldehyde. The frag-Diagnostic fragments were emitted at 383 (loss H 2 0 and CH3), mentation peaks at 323 (loss Hz0 and CH3), 271 (side-chain 253 (side-chain cleavage), 136, and 118, consistent with a dihy- (40) . This placental metabolite mass spectrum is very similar to previously reported 23,25(OH)2D3 mass spectra (40) (41) (42) .
Incubation of trophoblast and villous explants with supraphysiologic concentrations of
DISCUSSION
Placental 24,25(OH)2D3 synthesis was tentatively identified in several studies of placental 25(OH)D3 metabolism (1 6, 18-2 l), but in a recent study, Hollis et al. (22) suggested that human placenta may not express the enzymatic pathways necessary to synthesize 24,25(OH)zD3. The present investigations used cochromatography with internal authentic standards to advantage to identify placental 24,25(OH)2D3 more precisely and to localize its production to cyto-and syncytiotrophoblast. We identified the compound unequivocally by its UV spectrum and by mass spectrometry of both the native metabolite and its periodate cleavage product. Therefore, the disparity between our results and those of Hollis et al. (22) is difficult to explain. It is possible that their method of tissue preparation, which involved slow freezing and thawing of placental homogenates in the absence of protease inhibitors, may have permitted significant degradation of placental enzymes.
Renal 24-hydroxylation appears to be catalyzed by a distinct cytochrome P450 enzyme encoded by a novel gene (43, 44) . Ordinarily, 24-hydroxylase activity is not activated unless vitamin D target cells are stimulated by the administration of 1,25(OH)2D3 (27). This proved to be the case for placental fibroblasts, because the cells metabolized 25(OH)D3 when they were preincubated with 1,25(OH)zD3 but not after culture in vitamin D-deficient media. In contrast, we have shown that a remarkable feature of trophoblast 24-hydroxylation is its high basal activity, even when culture conditions should have depleted the tissue of vitamin D metabolites. It is also unlikely that 1,25(OH)2D3 present at the time of tissue harvesting was retained during the 2-to 4-d culture interval, because placenta in vitro very rapidly and efficiently metabolizes 1,25(OH)2D3 via the C24 and C23 oxidation pathways (45) .
In the intact, vitamin D-replete kidney, synthesis of 24,25(OH)2D3 is the major pathway for 25(OH)D3 metabolism (46) . In vitro administration of exogenous 1,25(OH)~D3 in a dose-dependent fashion increases recovery of 24,25(OH)zD3 and decreases recovery of 1,25(OH)zD3 in kidney (25, 26) and in extrarenal sites of 1,25(OH)2D3 synthesis (47, 48) . In contrast to kidney, placenta apparently uses 24-hydroxylation as the predominant 25(OH)D3 metabolic pathway regardless of the vitamin D status of the tissue.
Conceivably, this high basal 24-hydroxylase activity explains why we could not consistently demonstrate 1,25(OH)2D3 production when placenta was incubated with physiologic concentrations of 25(OH)D3, despite the use of very sensitive and specific HPLC systems to analyze vitamin Dl metabolites. These data are consistent with two previous reports that could not convincingly demonstrate 1,25(OH)zD3 production either by human placenta incubated with 6 nM 25(OH)D3 (20) enzymes (50)]. Only in this fashion, i.e. when we administered 6 to 10 pM 25(OH)D3 to cultured trophoblast or villous explants, could we consistently isolate a metabolite that possessed the chromatographic properties of 1,25(OH)zDs in three different HPLC systems. Our results suggest that this substrate range, which exceeds plasma 25(OH)D3 concentrations several-fold, saturates placental 24-hydroxylase and permits placental 1,25(OH)zD3 accumulation by inhibiting the further metabolism of 1,25(OH)~D3 by 24-hydroxylation. Because trophoblast 24-ELUTION TIME (rnin) Fig. 4 . HPLC identification of placental 24,25(OH)*D~ and its periodate cleavage product. Placental explants were incubated for 20 h with 10 pM 25(0H)D~. The lipid extracts were purified on a Zorbax-SIL column using a 2% isopropanol:hexane, and the putative placental 24,25(OH)zD3 peak was then rechromatographed using a methylene chloride-based solvent system. The final purified placental metabolite eluted as a single peak ( A ) with a retention time identical to that of the 24,25(OH)2D3 standard (B). A portion of the putative placental 24,25(OH)2D~ peak was then subjected to periodate cleavage as described in Materials and Methods. Sensitivity to periodate was demonstrated by HPLC using a 2% isopropano1:hexane solvent. The periodate cleavage products of the purified placental 24,25(OH)zD3 (C) and of the 24,25(OH)2D3 standard (D) eluted as single peaks with identical retention times in this system. hydroxylase activity apparently is not saturated under physiologic conditions, we speculate that 1,25(OH)~D3 synthesized locally in placenta may be rapidly catabolized, principally via C24 oxidation. Our preliminary observations indicate that this occurs when placenta is exposed to exogenous 1,25(OH)zD3 (45) .
M I 2
We speculate that another consequence of this high placental 24-hydroxylase activity might be the effective partition of the maternal and fetal circulations with respect to vitamin D3 metabolites. Human placenta performs a similar function in perinatal corticosteroid metabolism. In that instance, high levels of fetal plasma cortisone have been explained by the activity of placental I lp-dehydrogenase, which converts maternal cortisol to fetal cortisone (51, 52 systems studied to date, guinea pig kidney being a notable 21. Zerwekh JE, Breslau NA 1986 Human placental production of la-25-dihyexception (64), the predominant side-chain dihydroxylated vitadroxyvitamin DJ: biochemical characterization and production in normal subjects and patients with pseudohypoparathyroidism. J Clin Endocrinol min D3 metabolite is 24,25(OH)zD3, not 23,25(OH)zD3, although some of each compound is made (65) 
